MA
FLACU

MYDA Advisors’s Frazier Lifesciences Acquisition Corporation Unit FLACU Stock Holding History

MYDA Advisors’s Portfolio FLACU Stock Details FLACU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-410,299
Closed -$4.17M – 381
2021
Q1 		$4.17M Buy
410,299
+10,299
+3% +$110K 1.16% 17
2020
Q4 		$4.15M Buy
+400,000
New +$4.17M 1.23% 21

Other funds holding FLACU

FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
BCM
BlueCrest Capital Management St Helier, Jersey $1.69B AUM 20.01% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

MYDA Advisors's FLACU Position: Q2 2021 in Review

MYDA Advisors sold out of Frazier Lifesciences Acquisition Corporation Unit (FLACU) in Q2 2021, closing a stake of 410,299 shares — an estimated $4.17M sold.

MYDA Advisors first reported a position in FLACU in Q4 2020 and held it in 2 quarters. The position peaked at $4.17M in Q1 2021. 32 funds tracked by Wall St. Rank hold FLACU as of Q2 2021.

  • MYDA Advisors reported no remaining Frazier Lifesciences Acquisition Corporation Unit position as of Q2 2021 after selling out during the quarter.
  • MYDA Advisors sold 410,299 Frazier Lifesciences Acquisition Corporation Unit shares in Q2 2021, an estimated $4.17M.
  • MYDA Advisors first reported a position in Frazier Lifesciences Acquisition Corporation Unit in Q4 2020 and held it in 2 quarters.
  • MYDA Advisors's Frazier Lifesciences Acquisition Corporation Unit position peaked at $4.17M in Q1 2021.
  • 32 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Unit as of Q2 2021.

Based on MYDA Advisors's 13F filing for Q2 2021, filed 13 Aug 2021.